Did you know?

ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.

China Pharma Antibiotic OK’d for Trial

publication date: Oct 29, 2008

China Pharma Holdings was given the go-ahead by the SFDA to begin clinical trials of a novel antibiotic combination formula. China Pharma describes the new product as a third generation Cephalosporin antibiotic combined with a bacterial-enzyme inhibitor. Its clinical trial will begin in November. The complete run of clinical trials will take two years, according to the company. More details...